Quality of induced sputum using a human-powered nebuliser in a mobile human immunodeficiency virus testing service in South Africa

International Journal of Tuberculosis and Lung Disease

Volumn 15, Issue 8, 2011, Pages 1077-1081

  Kranzer, Katharina ^a,b   Olson, L ^c   Van Schaik, N ^a   Raditlhalo, E ^a   Hudson, E ^d   Panigrahi, P ^d   Bekker, L G ^b  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c Medical College of Wisconsin and Marquette University   (United States)

^d Northwestern University   (United States)

Author keywords

Diagnosis; Induced sputum; Resource limited; South Africa; Tuberculosis

Indexed keywords

ADULT; ARTICLE; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; ELECTRICAL EQUIPMENT; FEMALE; HIV TEST; HUMAN; INTERMETHOD COMPARISON; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL NEBULIZER; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; QUALITY CONTROL; SAMPLING; SOUTH AFRICA; SPUTUM ANALYSIS; SPUTUM CULTURE; SPUTUM INDUCTION; SPUTUM SMEAR;

ADULT; BACTERIOLOGICAL TECHNIQUES; EQUIPMENT DESIGN; FEMALE; HIV INFECTIONS; HUMANS; MALE; MASS SCREENING; MEDICALLY UNDERSERVED AREA; MIDDLE AGED; MOBILE HEALTH UNITS; MYCOBACTERIUM TUBERCULOSIS; NEBULIZERS AND VAPORIZERS; PREDICTIVE VALUE OF TESTS; SOUTH AFRICA; SPECIMEN HANDLING; SPUTUM; TIME FACTORS; TUBERCULOSIS, PULMONARY;

EID: 79960383948     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: 10.5588/ijtld.10.0684     Document Type: Article

References (32)

1. World Health Organization. Global tuberculosis control: epidemiology, strategy, financing: WHO report 2009. WHO/HTM/TB/2009.411. Geneva, Switzerland: WHO, 2009.
2. Wallis R S, Pai M, Menzies D, et al. Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice. Lancet 2010; 375: 1920-1937.
3. World Health Organization. Reduction of number of smears for the diagnosis of pulmonary TB. Geneva, Switzerland: WHO, 2007.
4. World Health Organization. Report of the 9th meeting of the Strategic and Technical Advisory Group on Tuberculosis (STAG-TB). Geneva, Switzerland: WHO, 2009.
5. Cruz A T, Starke J R. Clinical manifestations of tuberculosis in children. Paediatr Respir Rev 2007; 8: 107-117. (Pubitemid 46888353)
6. Lawson L, Yassin M A, Thacher T D, et al. Clinical presentation of adults with pulmonary tuberculosis with and without HIV infection in Nigeria. Scand J Infect Dis 2008; 40: 30-35.
7. Reid M J, Shah N S. Approaches to tuberculosis screening and diagnosis in people with HIV in resource-limited settings. Lancet Infect Dis 2009; 9: 173-184.
8. Swaminathan S, Paramasivan C N, Kumar S R, Mohan V, Venkatesan P. Unrecognised tuberculosis in HIV-infected patients: sputum culture is a useful tool. Int J Tuberc Lung Dis 2004; 8: 896-898. (Pubitemid 38937608)
9. Mtei L, Matee M, Herfort O, et al. High rates of clinical and subclinical tuberculosis among HIV-infected ambulatory subjects in Tanzania. Clin Infect Dis 2005; 40: 1500-1507. (Pubitemid 40628639)
10. Parry C M, Kamoto O, Harries A D, et al. The use of sputum induction for establishing a diagnosis in patients with suspected pulmonary tuberculosis in Malawi. Tubercle Lung Dis 1995; 76: 72-76.
11. McWilliams T, Wells A U, Harrison A C, Lindstrom S, Cameron R J, Foskin E. Induced sputum and bronchoscopy in the diagnosis of pulmonary tuberculosis. Thorax 2002; 57: 1010-1014. (Pubitemid 35440758)
12. Zar H J, Hanslo D, Apolles P, Swingler G, Hussey G. Induced sputum versus gastric lavage for microbiological confirmation of pulmonary tuberculosis in infants and young children: a prospective study. Lancet 2005; 365: 130-134. (Pubitemid 40091802)
13. Brown M, Varia H, Bassett P, Davidson R N, Wall R, Pasvol G. Prospective study of sputum induction, gastric washing, and bronchoalveolar lavage for the diagnosis of pulmonary tuberculosis in patients who are unable to expectorate. Clin Infect Dis 2007; 44: 1415-1420. (Pubitemid 46801582)
14. Paggiaro P L, Chanez P, Holz O, et al. Sputum induction. Eur Respir J Suppl 2002; 37 (Suppl): 3S-8S.
15. van Schaik N, Kranzer K, Wood R, Bekker L G. Earlier HIV diagnosis: are mobile services the answer? S Afr Med J 2010; 100: 671-674.
16. McCarter Y S, Robinson A. Quality evaluation of sputum specimens for mycobacterial culture. Am J Clin Pathol 1996; 105: 769-773. (Pubitemid 26178724)
17. Van Scoy R E. Bacterial sputum cultures. A clinician's viewpoint. Mayo Clin Proc 1977; 52: 39-41.
18. Geckler R W, Gremillion D H, McAllister C K, Ellenbogen C. Microscopic and bacteriological comparison of paired sputa and transtracheal aspirates. J Clin Microbiol 1977; 6: 396-399. (Pubitemid 8202544)
19. Murray P R, Washington J A. Microscopic and bacteriologic analysis of expectorated sputum. Mayo Clin Proc 1975; 50: 339-344.
20. Barlett R C. Medical microbiology: quality cost and clinical relevance. New York, NY, USA: Wiley, 1997.
21. Khan M S, Dar O, Tahseen S, Godfrey-Faussett P. Judging respiratory specimen acceptability for AFB microscopy: visual vs. microscopic screening. Trop Med Int Health 2009; 14: 571-575.
22. Kranzer K, Bekker L G, Lawn S D, et al. Intensified TB case finding among HIV-negative TB suspects linked to a mobile VCT service, Cape Town. 41st Union World Conference on Lung Health, Berlin, Germany. Abstract FA-100073-13. Int J Tuberc Lung Dis 2010; 14 (Suppl 2): S57.
23. Ayles H, Schaap A, Nota A, et al. Prevalence of tuberculosis, HIV and respiratory symptoms in two Zambian communities: implications for tuberculosis control in the era of HIV. PLoS One 2009; 4: e5602.
24. Corbett E L, Bandason T, Cheung Y B, et al. Prevalent infectious tuberculosis in Harare, Zimbabwe: burden, risk factors and implications for control. Int J Tuberc Lung Dis 2009; 13: 1231-1237.
25. Corbett E L, Charalambous S, Moloi V M, et al. Human immunodeficiency virus and the prevalence of undiagnosed tuberculosis in African gold miners. Am J Respir Crit Care Med 2004; 170: 673-679.
26. Corbett E L, Bandason T, Cheung Y B, et al. Epidemiology of tuberculosis in a high HIV prevalence population provided with enhanced diagnosis of symptomatic disease. PLoS Med 2007; 4: e22.
27. den Boon S, van Lill S W, Borgdorff M W, et al. High prevalence of tuberculosis in previously treated patients, Cape Town, South Africa. Emerg Infect Dis 2007; 13: 1189-1194. (Pubitemid 47359163)
28. Corbett E L, Marston B, Churchyard G J, De Cock K M. Tuberculosis in sub-Saharan Africa: opportunities, challenges, and change in the era of antiretroviral treatment. Lancet 2006; 367: 926-937.
29. Kimerling M E, Schuchter J, Chanthol E, et al. Prevalence of pulmonary tuberculosis among HIV-infected persons in a home care program in Phnom Penh, Cambodia. Int J Tuberc Lung Dis 2002; 6: 988-994. (Pubitemid 35408185)
30. Ferreira M M, Ferrazoli L, Palaci M, et al. TB and HIV infection among female inmates in Sao Paulo, Brazil: a prospective cohort study. J Acquir Immune Defic Syndr Hum Retrovirol 1996; 13: 177-183.
31. Desormeaux J, Johnson M P, Coberly J S, et al. Widespread HIV counseling and testing linked to a community-based tuberculosis control program in a high-risk population. Bull Pan Am Health Organ 1996; 30: 1-8. (Pubitemid 26115395)
32. Corbett E L, Bandason T, Duong T, et al. Comparison of two active case-finding strategies for community-based diagnosis of symptomatic smear-positive tuberculosis and control of infectious tuberculosis in Harare, Zimbabwe (DETECTB): a cluster-randomised trial. Lancet 2010; 376: 1244-1253.